Robert Potts is Director, International Quality at Vertex Pharmaceuticals for 9 + years. There he is responsible for the international expansion and product distribution internationally. He has over 14 years experience in the pharmaceutical industry. He has founded knowledge in GDP, GMP, GCP, GPVP.

We’re focused on discovering, developing and bringing innovative medicines to people with serious diseases so they can lead better lives. In pursuit of this mission, we are advancing a robust research pipeline that includes potentially transformative treatments for cystic fibrosis, pain, sickle cell disease, beta thalassemia, alpha-1 antitrypsin deficiency, APOL1-mediated kidney disease, Duchenne muscular dystrophy, type 1 diabetes and more.